According to the latest research by SkyQuest Technology, the home infusion therapy market was valued at US$ 34.54 billion in 2021, and it is expected to reach US$ 54.82 billion by 2028, with a CAGR of 6.8% during the forecast period of 2022 – 2028. The research provides up-to-date home infusion therapy market analysis of the current market landscape, latest trends, drivers, and overall market environment.
Multiple sclerosis, rheumatoid arthritis, Crohn’s disease, immunological insufficiency, and hemophilia are other conditions that can be treated using infusion therapy services. As a result, there is much potential for enterprises to expand their services thanks to the growth of the application sectors for infusion treatment. The demand for infusion therapy is anticipated to increase as a result.
The growth of diabetes, cancer and chronic pain patients is a major factor influencing the global market for infusion therapy.
According to the International Agency for Research on Cancer (IARC), there will be 10.3 million cancer-related deaths and 19.3 million new cases of cancer worldwide in 2020, which translates to 1 in 5 people developing cancer at some point in their lifetime and 1 in 8 men and 1 in 11 women dying of the disease. According to the International Diabetes Federation (IDF), there were 463 million people with diabetes globally in 2019 (aged 20 to 79), and that figure is projected to rise to 700 million by 2045. Additionally, diabetes claimed the lives of 4.2 million individuals worldwide in 2019.
Get Sample Report@https://skyquestt.com/sample-request/home-infusion-therapy-market
Governments in developing countries are modernizing the healthcare infrastructure, which is expected to increase access to healthcare. As a result, more infusion therapy services are predicted to be needed. The growing prevalence of chronic diseases in emerging countries is a profitable opportunity for the global infusion treatment market.
Read Market Research Report, “Global Home Infusion Therapy Market by Indication (Enteral Nutrition, Anti-Infective, Chemotherapy, Parenteral Nutrition, Hydration Therapy, Intravenous Immunoglobulin, Others), Product Analysis (Devices, Drugs, Services), and Region” —Forecast and Analysis 2022-2028” by SkyQuest.
Due to the existence of factors including the rising frequency of chronic diseases, the high cost of treatment, technical breakthroughs, and product launches, North America is one of the key areas in the home infusion therapy market. For instance, the Canadian Cancer Society estimates that there will be 225,800 new instances of cancer identified in Canada in 2020, along with 83,300 cancer-related fatalities.
Additionally, the American Cancer Society estimates that in 2019, there were approximately 1,762,450 newly diagnosed cancer cases and 606,880 cancer-related deaths in the United States. Breast cancer, lung cancer, prostate cancer, colorectal cancer, bladder cancer, and skin cancer are the most prevalent malignancies in the US. In addition, there is a growing shift away from acute care settings toward home care settings due to lower costs and improved patient mobility, which is anticipated to fuel the expansion even further. The demand for regional goods is also being boosted by improvements in the healthcare industry and the use of increasingly sophisticated medical items
On the other hand, the market for home healthcare offers development potential due to adequate insurance coverage for home infusion. Infusion treatment services are offered by a number of businesses in home healthcare settings, including Option Care Enterprises, CHI Health, etc. The price is also reimbursed by insurance.
On the other hand, a growing senior population, an increase in the burden of chronic diseases, and an increase in the number of government and industry activities in favor of home infusion therapy are expected to cause the market in Europe to grow at a significant rate.
During the forecast period, the market in Asia Pacific is anticipated to increase significantly and post the highest CAGR. This is attributable to both the surge in the use of cutting-edge technologies and the rising awareness of this treatment, which is used to treat a variety of chronic conditions. Additionally, the market in Asia Pacific is anticipated to grow during the projected period due to the rising prevalence of cancer, diabetes, and other long-term chronic diseases as well as an increase in the patient pool.
The market in the rest of the world is still in its early stages, but due to increased public awareness and a gradual shift in consumer choice toward home medical care, market growth in the region is anticipated to be boosted during the projected period.
The report published by SkyQuest Technology Consulting provides in-depth qualitative insights, historical data, and verifiable projections about home infusion therapy Market Revenue. The projections featured in the report have been derived using proven research methodologies and assumptions.
Speak With Our Analyst@https://skyquestt.com/speak-with-analyst/home-infusion-therapy-market
Research Finding
- Drivers- Two other reasons that are projected to boost demand for home infusion therapy globally over the course of the forecast period are the growing public awareness of the advantages of home treatment choices and the rapid technological developments in equipment designed for use at home.
- Restraints- Overdosing on pharmaceuticals can result in dangerous situations, a shortage of qualified nurses in developing and underdeveloped areas, irregular infusion device operation, and improper infusion device use, all of which could impede the development of this industry.
What does this Report Deliver?
- Market Estimation for 20+ Countries
- Home infusion therapy market demand by Region, Sub-Region, and Country
- Customization on Segments, Regions, and Company Profiles
- 100+ tables, 150+ Figures
- Global, Regional, and Country-specific home infusion therapy Market Trends
- Comprehensive Mapping of home infusion therapy Industry Parameters
- Attractive Investment Proposition in the Global home infusion therapy Industry
- Competitive Strategies Adopted by home infusion therapy Market Key Players
- Drivers, Restraints, Opportunities, Challenges, and the impact on the home infusion therapy Market Size
- Market growth rate till 2028
- Regulatory scenario, regional dynamics, and home infusion therapy market insights of leading countries in each region
- In-depth Market insights by Region and Country
- Market Segmentation Trend Analysis, Opportunities, and Growth
- Porter’s five force analysis to know the market’s condition
- Pricing Analysis and home infusion therapy Market Sales
- Parent market analysis
- Product portfolio benchmarking
SkyQuest has segmented the Global home infusion therapy Market based on Indication Analysis, Product, and Region:
- Global home infusion therapy Market by Indication Analysis (Revenue, US$ billion, 2021 – 2028)
- Anti-Infective
- Chemotherapy
- Hydration Therapy
- Enteral Nutrition
- Total Parenteral Nutrition
- Immunoglobulins
- Others
- Global Home Infusion Therapy Market by Product (Revenue, US$ billion, 2021 – 2028)
- Devices
- Drugs
- Services
- Global Home Infusion Therapy Market By Region (Revenue, US$ billion, 2021 – 2028)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Central & South America
- Brazil
- Rest of CSA
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of MEA
Key Players in the Global Home Infusion Therapy Market
- Option Care Health Inc. (US)
- Optum, Inc. (US)
- CareCentrix, Inc. (US)
- CVS Health (US)
- KabaFusion (US)
- PromptCare (US)
- Baxter International Inc. (US)
- Infusystem (US)
About Us:
SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.
Address:
1 Apache Way, Westford, Massachusetts 01886
Phone:
USA (+1) 617-230-0741
Email: sales@skyquestt.com
Find Insightful Blogs/Case Studies on Our Website:
